BridgeBio Pharma BBIO Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BridgeBio Pharma's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BridgeBio Pharma's total assets?
- BridgeBio Pharma (BBIO) reported total assets of $1.37B in Q1 2026.
- How has BridgeBio Pharma's total assets changed year-over-year?
- BridgeBio Pharma's total assets increased by 55.5% year-over-year, from $881.64M to $1.37B.
- What is the long-term trend for BridgeBio Pharma's total assets?
- Over 5 years (2020 to 2025), BridgeBio Pharma's total assets has grown at a 5.9% compound annual growth rate (CAGR), from $703.59M to $936.03M.
- What does total assets mean?
- The total value of everything the company owns.
- How do you interpret total assets?
- Growth generally signals capital expansion or successful fundraising, while a decline may indicate asset liquidation or significant cash burn.
- How does total assets compare across companies?
- Total assets vary widely based on the stage of clinical development and the size of the cash balance held for R&D.